You just read:

Almirall and Forest Laboratories Announce Positive Results for the Second Phase III Study for Aclidinium and Formoterol Combination in COPD

News provided by

Almirall, S.A. and Forest Laboratories, Inc.

May 02, 2013, 04:13 ET